MRNA Moderna, Inc. | US60770K1079
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 2.551.500.990 | 2.095.043.820 | 21.79% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -4,75 | -8,66 | 45.13% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 19 | 20 | 5.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |